top of page

OUR PIPELINE
Lario Therapeutics are targeting severe developmental and epileptic encephalopathies and neurodegenerative disorders.
CaV2.3 Modulators
LEAD PROGRAMMES:

LEAD GENERATION
LEAD OPTIMIZATION
IND ENABLING STUDIES
INDICATIONS
Genetic Epilepsies, Drug Refractory Epilepsy
HIT ID
Parkinson's Disease, other Neurodegenerative Disorders
Neurology Targets
ADDITIONAL PROGRAMMES:

LEAD GENERATION
LEAD OPTIMIZATION
IND ENABLING STUDIES
INDICATIONS
Genetic Hemiplegic Migraine, Epilepsy
HIT ID
Various Neurology
bottom of page